Reduce gait freezing with cueing
- Trial ID
- NCT06733077
- Official Title
- Development of Digital Diagnostics and Intervention Services for Parkinson's Disease
- Goal
- Reduce gait freezing with cueing
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- University of Exeter
- Study Type
- INTERVENTIONAL
- Enrollment
- 80 participants
- Conditions
- Healthy Controls, Parkinson's Disease
- Interventions
- gait with cueing wearable device and neuro-ocular performance
Plain-Language Summary
The goal is to improve digital diagnosis and support for walking problems in Parkinson's, especially daily freezing of gait and the fast, shuffling steps called festination. The approach combines a wearable cueing device that delivers timed sensory prompts to the legs to help regularize stepping, with neuro-ocular tests that measure eye and visual-motor performance to detect instability and help tailor the intervention. Adults with Parkinson's who report daily freezing or festination, can walk for at least 5 minutes (with or without an aid), have MoCA scores above 21, and normal or corrected vision are eligible. Healthy adults can join as controls if they can walk at least 3 minutes and meet the same vision and cognition requirements, while people with implants like deep brain stimulators or pacemakers or skin issues on the calves are excluded.
Locations
- University of Exeter, Exeter, United Kingdom
Frequently Asked Questions
- What is this trial testing?
- This trial is studying gait with cueing wearable device and neuro-ocular performance. The goal is to improve digital diagnosis and support for walking problems in Parkinson's, especially daily freezing of gait and the fast, shuffling steps called festination. The approach combines a wearable cueing device that delivers timed sensory prompts to the legs to help regularize stepping, with neuro-ocular tests that measure eye and visual-motor performance to detect instability and help tailor the intervention. Adults with Parkinson's who report daily freezing or festination, can walk for at least 5 minutes (with or without an aid), have MoCA scores above 21, and normal or corrected vision are eligible. Healthy adults can join as controls if they can walk at least 3 minutes and meet the same vision and cognition requirements, while people with implants like deep brain stimulators or pacemakers or skin issues on the calves are excluded.
- Who can participate?
- Participants must be at least 18 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 1 year and 3 months.